Details of the Drug Reposition

General Information of This Drug (ID: DMA2JQD)

Drug Name	P28 cell penetrating peptide DMA2JQD

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Central nervous system disease	DISFB8P5	8A04-8D87	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of CDG Therapeutics.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)